European advisory panel recommends approval of Spark's gene therapy
September 21, 2018 at 09:31 AM EDT
A final decision on Luxturna's use in the European Union is expected within the next two months
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|